Inventor · disambiguated record
Ryan Swanson
Also filed as: SWANSON RYAN · SWANSON RYAN M · SWANSON RYAN MICHAEL
26 granted patents·22 pending applications·119 citations·filing 2002–2025
96Inventor score
Top patents by PatentIndex Score
48 records- 0198US11230588B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Jan 25, 2022·6 cites·29 claims
- 0298US11117949B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Sep 14, 2021·13 cites·30 claims
- 0398US11117950B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Sep 14, 2021·13 cites·28 claims
- 0498US11117948B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Sep 14, 2021·13 cites·30 claims
- 0598US11096988B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Aug 24, 2021·13 cites·19 claims
- 0697US11078282B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2017·Granted Aug 3, 2021·17 cites·33 claims
- 0795US11359022B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Jun 14, 2022·2 cites·19 claims
- 0895US11319359B2Immunomodulatory proteins with tunable affinitiesALPINE IMMUNE SCIENCES INC·Filed 2016·Granted May 3, 2022·9 cites·12 claims
- 0994US11639375B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2018·Granted May 2, 2023·4 cites·28 claims
- 1094US11498967B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2022·Granted Nov 15, 2022·2 cites·24 claims
- 1194US11479609B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2022·Granted Oct 25, 2022·2 cites·18 claims
- 1294US10882914B2ICOS ligand variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2017·Granted Jan 5, 2021·8 cites·45 claims
- 1393US11753458B2CTLA-4 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2018·Granted Sep 12, 2023·6 cites·31 claims
- 1491US11613566B2Variant ICOS ligand immunomodulatory proteins and related compositions and methodsALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Mar 28, 2023·1 cites·4 claims
- 1586US12358969B2CTLA-4 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2023·Granted Jul 15, 2025·0 cites·37 claims
- 1683US12065476B2PD-1 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2019·Granted Aug 20, 2024·2 cites·11 claims
- 1783US10357561B2BTNL9 proteins, nucleic acids, and antibodies and uses thereofAMGEN INC·Filed 2015·Granted Jul 23, 2019·4 cites·9 claims
- 1883US2025320272A1Ctla-4 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2025·Application pending·0 cites
- 1982US2024409660A1Icos ligand variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2024·Application pending·0 cites
- 2082US2024002466A1Cd80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2023·Application pending·0 cites
- 2181US11459370B2BTNL3 proteins, nucleic acids and antibodies and uses thereofAMGEN INC·Filed 2019·Granted Oct 4, 2022·1 cites·1 claims
- 2281US2023136723A1Cd80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2022·Application pending·0 cites
- 2379US2023250152A1Ctla-4 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2023·Application pending·0 cites
- 2478US11471488B2CD155 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2017·Granted Oct 18, 2022·1 cites·22 claims
- 2577US11732022B2PD-L2 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2018·Granted Aug 22, 2023·1 cites·9 claims
- 2677US2025361283A1Btnl3 proteins, nucleic acids and antibodies and uses thereofAMGEN INC·Filed 2025·Application pending·0 cites
- 2777US2023192802A1Btnl3 proteins, nucleic acids and antibodies and uses thereofAMGEN INC·Filed 2022·Application pending·0 cites
- 2877US2024360197A1Pd-1 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2024·Application pending·0 cites
- 2976US2023235012A1Variant icos ligand immunomodulatory proteins and related compositions and methodsALPINE IMMUNE SCIENCES INC·Filed 2023·Application pending·0 cites
- 3074US12486312B2Immunomodulatory proteins with tunable affinitiesALPINE IMMUNE SCIENCES INC·Filed 2022·Granted Dec 2, 2025·0 cites·25 claims
- 3173US11834490B2CD112 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2017·Granted Dec 5, 2023·1 cites·35 claims
- 3272US12110339B2ICOS ligand variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2020·Granted Oct 8, 2024·0 cites·21 claims
- 3366US12281147B2Interleukin 21 variantsA ALPHA BIO INC·Filed 2024·Granted Apr 22, 2025·0 cites·19 claims
- 3464US12297253B2Multi-domain immunomodulatory proteins and methods of use thereofALPINE IMMUNE SCIENCES INC·Filed 2019·Granted May 13, 2025·0 cites·37 claims
- 3562US2025361308A1NEO-2/15 Variants and Uses Thereof for Preferentially Stimulating T-Regulatory CellsNEUROGENE INC·Filed 2023·Application pending·0 cites
- 3661US2020283500A1Variant icos ligand immunomodulatory proteins and related compositions and methodsALPINE IMMUNE SCIENCES INC·Filed 2018·Application pending·0 cites
- 3761US2023381229A1Cd155 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2022·Application pending·0 cites
- 3860US2025163127A1Multi-domain immunomodulatory proteins and methods of use thereofALPINE IMMUNE SCIENCES INC·Filed 2025·Application pending·0 cites
- 3958US12421288B2Interferon alpha-2 variantsA ALPHA BIO·Filed 2024·Granted Sep 23, 2025·0 cites·16 claims
- 4058US2015166630A1Btnl3 proteins, nucleic acids, and antibodies and uses thereofAMGEN INC·Filed 2013·Application pending·0 cites
- 4155US2023220039A1Pd-l1 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2018·Application pending·0 cites
- 4247US2022177587A1Methods and uses of variant cd80 fusion proteins and related constructsALPINE IMMUNE SCIENCES INC·Filed 2019·Application pending·0 cites
- 4347US2003068327A1Compositions and methods for the diagnosis and threatment of herpes simplex virus infectionCORIXA CORP·Filed 2002·Application pending·0 cites
- 4446US2022218785A1Methods and uses of variant icos ligand (icosl) fusion proteinsALPINE IMMUNE SCIENCES INC·Filed 2020·Application pending·0 cites
- 4544US2013101590A1Btnl9 proteins, nucleic acids, and antibodies and uses thereofARNETT HEATHER A·Filed 2011·Application pending·0 cites
- 4643US2003228279A1Compositions and methods for viral deliveryCORIXA CORP·Filed 2002·Application pending·0 cites
- 4742US2020040059A1Secretable variant immunomodulatory proteins and engineered cell therapyALPINE IMMUNE SCIENCES INC·Filed 2017·Application pending·0 cites
- 4839US2018256644A1Tunable variant immunoglobulin superfamily domains and engineered cell therapyALPINE IMMUNE SCIENCES INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ryan Swanson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →